Point72 Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Buy |
7,042,373
+4,254,742
| +153% | +$17M | 0.06% | 335 |
|
|
2025
Q1 | $8.86M | Sell |
2,787,631
-242,380
| -8% | -$771K | 0.02% | 553 |
|
|
2024
Q4 | $16.2M | Sell |
3,030,011
-2,532,718
| -46% | -$13.6M | 0.04% | 444 |
|
|
2024
Q3 | $29.4M | Sell |
5,562,729
-401,781
| -7% | -$2.12M | 0.07% | 279 |
|
|
2024
Q2 | $10.9M | Buy |
+5,964,510
| New | +$10.9M | 0.03% | 475 |
|
|
2022
Q2 | – | Sell |
-745,000
| Closed | -$1.22M | – | 1089 |
|
|
2022
Q1 | $1.22M | Sell |
745,000
-50,000
| -6% | -$82K | ﹤0.01% | 851 |
|
|
2021
Q4 | $1.92M | Buy |
795,000
+220,000
| +38% | +$530K | 0.01% | 772 |
|
|
2021
Q3 | $2.78M | Buy |
+575,000
| New | +$2.78M | 0.01% | 699 |
|
|
2017
Q4 | – | Sell |
-195,034
| Closed | -$3.11M | – | 779 |
|
|
2017
Q3 | $3.11M | Sell |
195,034
-37,349
| -16% | -$595K | 0.01% | 510 |
|
|
2017
Q2 | $2.81M | Sell |
232,383
-175,894
| -43% | -$2.13M | 0.02% | 508 |
|
|
2017
Q1 | $8.48M | Buy |
+408,277
| New | +$8.48M | 0.05% | 393 |
|